GHRS
GH Research PLC

527
Loading...
Loading...
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
50

Frequently Asked Questions

What is Market Cap of GH Research PLC?
What is the 52-week high for GH Research PLC?
What is the 52-week low for GH Research PLC?
What is GH Research PLC stock price today?
What was GH Research PLC stock price yesterday?
What is the PE ratio of GH Research PLC?
What is the Price-to-Book ratio of GH Research PLC?
What is the 50-day moving average of GH Research PLC?
How many employess does GH Research PLC has?

Latest GHRS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.